Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms

    Chemotherapy has limited efficacy in advanced digestive high-grade neuroendocrine neoplasms (HG-NEN) and prognosis is dismal. Predictive markers for palliative chemotherapy are lacking, and prognostic markers ...

    Hege Elvebakken, Andreas Venizelos, Aurel Perren in British Journal of Cancer (2024)

  2. Article

    Open Access

    Role of the fatty pancreatic infiltration in pancreatic oncogenesis

    Although pancreatic precancerous lesions are known to be related to obesity and fatty pancreatic infiltration, the mechanisms remain unclear. We assessed the role of fatty infiltration in the process of pancre...

    Sonia Frendi, Chloé Martineau, Hélène Cazier, Rémy Nicolle in Scientific Reports (2024)

  3. Article

    Open Access

    Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms

    The optimal treatment for metastatic high-grade gastroenteropancreatic (GEP) neuroendocrine neoplasms when Ki-67 ≤55% is unknown. A prospective multi-centre phase 2 study was performed to evaluate the efficacy...

    Siren Morken, Seppo W. Langer, Anna Sundlöv in British Journal of Cancer (2023)

  4. No Access

    Article

    An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs

    Digestive neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms found throughout the digestive tract, with different behaviour and genetic background. In the last few years, nomenclature and W...

    Anne Couvelard, Jérôme Cros in Virchows Archiv (2022)

  5. No Access

    Reference Work Entry In depth

    Glucagon Cell Hyperplasia and Neoplasia

    Anne Couvelard in Endocrine Pathology (2022)

  6. No Access

    Reference Work Entry In depth

    Glucagonoma

    Anne Couvelard, Jérôme Cros in Endocrine Pathology (2022)

  7. No Access

    Article

    Pathogenic ATM Variant-Harbouring Well-Differentiated Aggressive Type 1 Gastric Neuroendocrine Tumour with High-grade Features (G3 NET): a New Addition to the Clinical and Pathological Spectrum of Gastric Neuroendocrine Neoplasms

    Gastric type 1 neuroendocrine tumours are considered to have low rates of proliferation and a good prognosis. We report here a patient with an aggressive well-differentiated high-grade gastric neuroendocrine t...

    Hussein Nassereddine, Matthieu Chicaud, Khedidja Rebah in Endocrine Pathology (2021)

  8. No Access

    Article

    Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome

    Dilatation of the main pancreatic duct (MPD) is rare in pancreatic neuroendocrine neoplasm (panNEN) and may be due to different mechanisms. We compared the imaging and pathological characteristics as well as t...

    Marco Dioguardi Burgio, Jérome Cros, Nicola Panvini, Thomas Depoilly in European Radiology (2021)

  9. Article

    Open Access

    Bariatric surgery induces a new gastric mucosa phenotype with increased functional glucagon-like peptide-1 expressing cells

    Glucagon-Like Peptide-1 (GLP-1) undergoes rapid inactivation by dipeptidyl peptidase-4 (DPP4) suggesting that target receptors may be activated by locally produced GLP-1. Here we describe GLP-1 positive cells ...

    Lara Ribeiro-Parenti, Anne-Charlotte Jarry, Jean-Baptiste Cavin in Nature Communications (2021)

  10. Article

    Correction to: Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging

    The original version of this article, published on 19 August 2016, unfortunately contained a mistake.

    Emad Lotfalizadeh, Maxime Ronot, Mathilde Wagner, Jérôme Cros in European Radiology (2020)

  11. No Access

    Article

    Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma

    To retrospectively characterize the molecular features of Non-Small Cell Lung Carcinomas (NSCLC) with peritoneal carcinomatosis (PC), clinicopathological data of 12 patients diagnosed with NSCLC and PC between...

    Hussein Nassereddine, Aurélie Sannier, Solenn Brosseau in Pathology & Oncology Research (2020)

  12. Article

    Open Access

    Long-term consequences of one anastomosis gastric bypass on esogastric mucosa in a preclinical rat model

    Although bariatric surgery is proven to sustain weight loss in morbidly obese patients, long-term adverse effects have yet to be fully characterized. This study compared the long-term consequences of two commo...

    Matthieu Siebert, Lara Ribeiro-Parenti, Nicholas D. Nguyen in Scientific Reports (2020)

  13. No Access

    Living Reference Work Entry In depth

    Glucagon Cell Hyperplasia and Neoplasia

    Anne Couvelard in Encyclopedia of Pathology

  14. No Access

    Living Reference Work Entry In depth

    Glucagonoma

    Anne Couvelard, Jérôme Cros in Encyclopedia of Pathology

  15. No Access

    Article

    Non-branched microcysts of the pancreas on MR imaging of patients with pancreatic tumors who had pancreatectomy may predict the presence of pancreatic intraepithelial neoplasia (PanIN): a preliminary study

    To evaluate whether pancreatic parenchymal abnormalities on magnetic resonance imaging (MRI) are associated with pancreatic intraepithelial neoplasia (PanIN) on histology.

    Marie-Pierre Vullierme, Lina Menassa, Anne Couvelard in European Radiology (2019)

  16. Article

    Open Access

    Obesity-induced pancreatopathy in rats is reversible after bariatric surgery

    Obesity is a risk factor for pancreatic diseases. Bariatric surgery is one of the most efficient treatments of morbid obesity. The aims were to assess pancreatic endocrine and exocrine lesions in obese rats, t...

    Vinciane Rebours, Philippe Garteiser, Lara Ribeiro-Parenti in Scientific Reports (2018)

  17. No Access

    Article

    A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component

    Hussein Nassereddine, Nicolas Poté, Nathalie Théou-Anton in Virchows Archiv (2017)

  18. No Access

    Article

    Long-Term Evaluation of Biliary Reflux After Experimental One-Anastomosis Gastric Bypass in Rats

    Controversy remains regarding biliary reflux after one-anastomosis gastric bypass (OAGB). The aim of this “pilot” study was to analyze biliary reflux and its potential long-term consequences on esogastric muco...

    Matthieu Bruzzi, Henri Duboc, Caroline Gronnier, Dominique Rainteau in Obesity Surgery (2017)

  19. No Access

    Article

    Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging

    To evaluate the value of MR imaging including diffusion-weighted imaging (DWI) for the grading of pancreatic neuroendocrine tumours (pNET).

    Emad Lotfalizadeh, Maxime Ronot, Mathilde Wagner, Jérôme Cros in European Radiology (2017)

  20. No Access

    Chapter

    Glucagonoma

    Glucagonoma represents about 2 % of the pancreatic neuroendocrine tumors (PanNET). They are accompanied by a diabetico-dermatogenic functional syndrome with typical clinical symptoms due to the raised hormone....

    Anne Couvelard, Olivia Hentic in Pancreatic Neuroendocrine Neoplasms (2015)

previous disabled Page of 2